HBAN
47
7
TRV
34
4
TGNA
48
5
WAT
55
11
MAT
41
2
STT
48
4
EA
41
3
AAP
26
5
HOG
29
4
NKE
36
2
STZ
42
2
ES
12
3
CRM
65
6
NTRS
35
10
ZTS
38
4
HCA
37
7
FOXA
67
5
NDAQ
46
2
APH
53
3
AON
25
4
HBAN
47
7
TRV
34
4
TGNA
48
5
WAT
55
11
MAT
41
2
STT
48
4
EA
41
3
AAP
26
5
HOG
29
4
NKE
36
2
STZ
42
2
ES
12
3
CRM
65
6
NTRS
35
10
ZTS
38
4
HCA
37
7
FOXA
67
5
NDAQ
46
2
APH
53
3
AON
25
4
Financhill
Back

Bactech Environmental Vs. Kymera Therapeutics Industry Stock Comparison

Sell
25

BAC.CX
Bactech Environmental

Last Price:
$0.0300
Seasonality Move:
67.48%
Sell
39

KYMR
Kymera Therapeutics

Last Price:
$40.75
Seasonality Move:
2.79%
Sell
25
Bactech Environmental (BAC.CX) is a Sell

Is Bactech Environmental a Buy, Sell or Hold?

  • The current Bactech Environmental [BAC.CX] share price is $0.0250. The Score for BAC.CX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • BAC.CX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $40.64. The Score for KYMR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • KYMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BAC.CX Stock Price Chart

What is Bactech Environmental's stock price today?

  • The Bactech Environmental share price today is $0.0250
    The current trend is relatively stagnant and BAC.CX is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $40.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

BAC.CX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 40.67 Sell
Chaikin Money Flow: -221000 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.03 - 0.03) Sell
Bollinger Bands (100): (0.022 - 0.042) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.61 Sell
Relative Strength Index (14 RSI): 40.07 Sell
Chaikin Money Flow: 1023886 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.59 - 46.41) Sell
Bollinger Bands (100): (42.92 - 48.78) Sell

BAC.CX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.03 Sell
20-day SMA: 0.03 Sell
50-day SMA: 0.03 Sell
200-day SMA: 0.04 Sell
8-day EMA: 0.03 Sell
20-day EMA: 0.03 Sell
50-day EMA: 0.03 Sell
200-day EMA: 0.04 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.68 Sell
20-day SMA: 44.26 Sell
50-day SMA: 45.89 Sell
200-day SMA: 41.31 Sell
8-day EMA: 41.51 Sell
20-day EMA: 43.39 Sell
50-day EMA: 44.87 Sell
200-day EMA: 41.09 Sell

Bactech Environmental Earnings Growth & BAC.CX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.37 per share.

Bactech Environmental Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):